Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Pyridostigmine Therapy After Transurethral Resection of Prostate in Cases with Underactive Urinary Bladder: Prospective Randomized Trial

NCT06753071 is registered in ClinicalTrials.gov with Menoufia University as lead sponsor.

NCT NCT06753071
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06753071 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Pyridostigmine Therapy After Transurethral Resection of Prostate in Cases with Underactive Urinary Bladder: Prospective Randomized Trial
Lead sponsor
Menoufia University
Phase
Phase 4
Overall status
Completed
Start date
April 1, 2024
Completion date
January 1, 2025
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bph (benign prostatic hyperplasia), turp(transurethral resection of prostate), underactive bladder